Literature DB >> 18455950

Stroke of the substance nigra and parkinsonism as first manifestation of systemic lupus erythematosus.

San-Juan Orta Daniel1, Rodríguez-Ortiz Ulises.   

Abstract

The authors report one case of parkinsonism associated with systemic lupus erythematosus (SLE): a 45-year-old woman, who presented with a strategic infarct of the right substance nigra secondary to vasculitis, and contralateral symptoms. Other causes of parkinsonism were excluded. She had a partial response to therapy with levodopa. Parkinsonism as the first manifestation of lupus is extremely rare. This is the first reported case with strategic infarction in the substance nigra secondary to vasculitis in a patient with SLE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18455950     DOI: 10.1016/j.parkreldis.2007.08.001

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  4 in total

1.  Tumefactive demyelination associated with systemic lupus erythematosus.

Authors:  Rajesh Verma; Kamal Arya
Journal:  BMJ Case Rep       Date:  2012-05-11

Review 2.  Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  José Fidel Baizabal-Carvallo; Cecilia Bonnet; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2013-04-13       Impact factor: 3.575

3.  Neural differentiation of transplanted neural stem cells in a rat model of striatal lacunar infarction: light and electron microscopic observations.

Authors:  Vilma C Muñetón-Gómez; Ernesto Doncel-Pérez; Ana P Fernandez; Julia Serrano; Andrea Pozo-Rodrigálvarez; Lara Vellosillo-Huerta; Julian S Taylor; Gloria P Cardona-Gómez; Manuel Nieto-Sampedro; Ricardo Martínez-Murillo
Journal:  Front Cell Neurosci       Date:  2012-08-02       Impact factor: 5.505

Review 4.  Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature.

Authors:  Rikitha Menezes; Alexander Pantelyat; Izlem Izbudak; Julius Birnbaum
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.